Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

862

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Acne Vulgaris
Interventions
DRUG

Onexton

Topical gel for treating acne

DRUG

Clindamycin/benzoyl peroxide gel

Generic Clindamycin/benzoyl peroxide gel for treating acne

DRUG

Placebo

Vehicle gel used as a placebo

Trial Locations (17)

23507

Clinical Research Assoc. of Tidewater, Norfolk

27262

Dermatology Consulting Services, High Point

31406

Meridian Clinical Research, Savannah

33144

AMB Research Center, Miami

33761

Tampa Bay Medical Research, Clearwater

45246

Sterling Research Group, Cincinnati

63141

Sundance Clinical Research, St Louis

67010

Heartland Research Assoc, Augusta

67207

Heartland Research Assoc, Wichita

68134

Meridian Clinical Research, Omaha

68701

Meridian Clinical Research, Norfolk

75234

Reseacr Across America, Dallas

77701

Discover Research, Beaumont

77802

DiscoverResearch Inc, Bryan

85032

Alliance Dermatology, Phoenix

91911

Estudy, Chula Vista

91942

Estudy, La Mesa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT02616614 - Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris | Biotech Hunter | Biotech Hunter